Brief: Biotec Pharmacon Says ArcticZymes AS secures first supply agreement for utility of Salt Active Nuclease in Gene Therapy
30/09/2018 22:00
Sept 30 (Reuters) - Biotec Pharmacon ASA BIOTEC.OL :
* BIOTEC PHARMACON-UNIT ARCTICZYMES SECURES SUPPLY AGREEMENT
FOR
UTILITY OF SALT ACTIVE NUCLEASE (SAN) IN CGMP MANUFACTURING OF
VIRUSES FOR GENE THERAPY
* COMMERCIAL VALUE OF INDIVIDUAL DEALS IS ANTICIPATED TO BE
IN 1-3
MNOK RANGE PER ANNUM
Source text for Eikon: ID:nWkr13j8Gz
Further company coverage: BIOTEC.OL
((Reuters.Briefs@thomsonreuters.com;))